Zendal, Applied scientific excellence in biotechnology and pharmaceuticals for human and animal health.

O Porriño, June 27, 2024.- The Zendal group launches the V edition of its International Zendal Awards, the annual awards organized by the biopharmaceutical group. These awards were born in 2019 with the aim of boosting, making visible, promoting and recognizing new research projects in the field of human and animal health. Year after year, the number of nominations and projects has been growing gradually, which is a sign of the scientific quality of many of the research groups both nationally and internationally.

These awards are open to institutions and work teams, both public and private. Two categories are established: human health, with 40,000 euros, and animal health, with 25,000 euros.

Research, development, manufacturing and marketing.

For the awarding of the prizes, special consideration will be given to those candidates who have made relevant contributions in research, biotechnology and health with innovative solutions and a transformative capacity. In addition, in order to guarantee a choice in the most objective terms possible, factors such as the viability of the project, its applicability, and its contribution to the improvement of life in terms of progress and well-being will be taken into account.

Nominations can be submitted until October 4 through the Zendal website, https://www.zendal.com/

A tribute award is also granted, aimed at recognizing a professional career. In this case, it is aimed at people who have contributed with their work and merits in the scientific area, to the development of vaccines and other health products, prevention, biotechnology and the One Health concept.

More than 30 years of success in the biopharmaceutical sector, with advances that speak of our experience and our values.

Previous award winners include María A. Blasco, director of the Spanish National Cancer Research Center (CNIO), Dr. Ángel Carracedo, director of the Galician Public Foundation of Xenomic Medicine (SERGAS-Xunta de Galicia), María Vallet Regí, head of the CIBER-BBN group at the Complutense University of Madrid or Inmaculada Ibáñez de Cáceres, PhD in Molecular Biology.

The jury will be formed by an International Scientific Committee made up of leading personalities in the field of biotechnology and health, as well as a president and a secretary of the Zendal Group.

About Zendal Group

Zendal is the corporate brand of the biotechnology group focused on the research, development, manufacture and commercialization of human and animal vaccines and other high value-added pharmaceutical products for the health sector. It has three R&D centers and several biopharmaceutical production plants in its laboratories in O Porriño, León, Barcelona and Paredes de Coura (Portugal).

Original News: Zendal Group launches the 5th edition of its International Zendal Awards for human and animal health projects – Beatriz Díaz Lorenzo (28/06/2024)

For BIOGA, it is a priority to promote intersectoral collaboration with other entities and to promote national and international networking activities. If you want to know more about us, please visit the following link.